Concepts (253)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hippocampus | 9 | 2017 | 860 | 1.700 |
Why?
|
| Fragile X Syndrome | 3 | 2017 | 155 | 1.330 |
Why?
|
| rac1 GTP-Binding Protein | 5 | 2017 | 68 | 1.160 |
Why?
|
| Multiple Sclerosis | 11 | 2003 | 386 | 0.880 |
Why?
|
| rac GTP-Binding Proteins | 3 | 2011 | 26 | 0.870 |
Why?
|
| Actins | 2 | 2017 | 343 | 0.860 |
Why?
|
| Fear | 5 | 2017 | 205 | 0.840 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2009 | 152 | 0.770 |
Why?
|
| Myelin Basic Protein | 10 | 2003 | 68 | 0.720 |
Why?
|
| Synapses | 4 | 2013 | 470 | 0.720 |
Why?
|
| Cell Membrane | 2 | 2017 | 483 | 0.680 |
Why?
|
| Long-Term Potentiation | 4 | 2017 | 163 | 0.530 |
Why?
|
| Lactobacillus | 4 | 1999 | 47 | 0.500 |
Why?
|
| Streptococcus | 4 | 1999 | 63 | 0.500 |
Why?
|
| Learning | 2 | 2017 | 375 | 0.490 |
Why?
|
| Bifidobacterium | 4 | 1999 | 70 | 0.480 |
Why?
|
| T-Lymphocytes | 12 | 2003 | 1770 | 0.460 |
Why?
|
| Cytokines | 9 | 2003 | 1378 | 0.460 |
Why?
|
| Brain | 5 | 2015 | 3224 | 0.460 |
Why?
|
| Neuronal Plasticity | 3 | 2013 | 288 | 0.440 |
Why?
|
| Herpesvirus 6, Human | 3 | 2003 | 55 | 0.430 |
Why?
|
| Memory | 5 | 2017 | 358 | 0.410 |
Why?
|
| Cognitive Dysfunction | 1 | 2017 | 317 | 0.400 |
Why?
|
| Brain Diseases | 1 | 2015 | 310 | 0.390 |
Why?
|
| Dendritic Spines | 1 | 2011 | 61 | 0.350 |
Why?
|
| Fragile X Mental Retardation Protein | 3 | 2017 | 126 | 0.340 |
Why?
|
| Neuropeptides | 1 | 2011 | 116 | 0.340 |
Why?
|
| Dizocilpine Maleate | 1 | 2009 | 18 | 0.320 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 501 | 0.320 |
Why?
|
| Cognition | 1 | 2015 | 817 | 0.320 |
Why?
|
| Aminoquinolines | 3 | 2017 | 35 | 0.320 |
Why?
|
| Dendrites | 1 | 2011 | 204 | 0.320 |
Why?
|
| Anxiety | 2 | 2013 | 1006 | 0.300 |
Why?
|
| Cell Fractionation | 2 | 2006 | 28 | 0.300 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 760 | 0.300 |
Why?
|
| Cognition Disorders | 1 | 2013 | 578 | 0.290 |
Why?
|
| Probiotics | 3 | 1999 | 229 | 0.280 |
Why?
|
| Theta Rhythm | 2 | 2017 | 24 | 0.280 |
Why?
|
| Animals | 19 | 2017 | 36203 | 0.270 |
Why?
|
| Mental Disorders | 1 | 2015 | 895 | 0.270 |
Why?
|
| Mice | 14 | 2013 | 18937 | 0.270 |
Why?
|
| Association Learning | 1 | 2007 | 21 | 0.270 |
Why?
|
| Avoidance Learning | 1 | 2007 | 59 | 0.260 |
Why?
|
| Synaptic Membranes | 1 | 2006 | 23 | 0.250 |
Why?
|
| Synaptosomes | 1 | 2006 | 31 | 0.250 |
Why?
|
| Pyrimidines | 3 | 2017 | 420 | 0.250 |
Why?
|
| Nuclear Proteins | 1 | 2013 | 1341 | 0.250 |
Why?
|
| N-Methylaspartate | 1 | 2006 | 28 | 0.250 |
Why?
|
| Roseolovirus Infections | 2 | 2003 | 30 | 0.240 |
Why?
|
| Mice, Inbred C57BL | 7 | 2011 | 4823 | 0.240 |
Why?
|
| Protein Transport | 1 | 2006 | 389 | 0.230 |
Why?
|
| NADPH Oxidases | 1 | 2005 | 115 | 0.220 |
Why?
|
| Mice, Knockout | 4 | 2017 | 3979 | 0.220 |
Why?
|
| Myelin Proteolipid Protein | 2 | 2001 | 27 | 0.220 |
Why?
|
| Disease Models, Animal | 3 | 2011 | 4759 | 0.200 |
Why?
|
| Transcription Factors | 1 | 2013 | 2720 | 0.190 |
Why?
|
| Oligodendroglia | 1 | 2002 | 79 | 0.190 |
Why?
|
| Cytosol | 2 | 2017 | 167 | 0.190 |
Why?
|
| Neurogenesis | 2 | 2015 | 223 | 0.190 |
Why?
|
| Myelin Sheath | 1 | 2002 | 127 | 0.180 |
Why?
|
| Leukocytes | 2 | 1999 | 216 | 0.170 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2011 | 130 | 0.170 |
Why?
|
| DNA, Viral | 1 | 2002 | 496 | 0.170 |
Why?
|
| Autoimmunity | 2 | 2001 | 181 | 0.170 |
Why?
|
| Analysis of Variance | 4 | 2011 | 1033 | 0.170 |
Why?
|
| Autoantibodies | 2 | 2002 | 464 | 0.170 |
Why?
|
| Glycoproteins | 1 | 2002 | 381 | 0.170 |
Why?
|
| Viral Proteins | 1 | 2002 | 361 | 0.170 |
Why?
|
| In Vitro Techniques | 4 | 2011 | 960 | 0.160 |
Why?
|
| Antibodies, Viral | 3 | 2003 | 1204 | 0.160 |
Why?
|
| Nitric Oxide | 2 | 1999 | 487 | 0.160 |
Why?
|
| Lactobacillus acidophilus | 1 | 1999 | 2 | 0.160 |
Why?
|
| Yogurt | 1 | 1999 | 13 | 0.160 |
Why?
|
| Cholera Toxin | 1 | 1999 | 51 | 0.150 |
Why?
|
| Cell Line | 8 | 2003 | 2855 | 0.150 |
Why?
|
| Ergosterol | 1 | 1998 | 2 | 0.150 |
Why?
|
| Freund's Adjuvant | 1 | 1998 | 27 | 0.150 |
Why?
|
| Immunoglobulins | 1 | 1999 | 169 | 0.150 |
Why?
|
| Immunoglobulin A | 1 | 1999 | 215 | 0.140 |
Why?
|
| Macrophages | 2 | 1999 | 697 | 0.140 |
Why?
|
| Reflex, Acoustic | 1 | 2017 | 4 | 0.140 |
Why?
|
| Prepulse Inhibition | 1 | 2017 | 4 | 0.140 |
Why?
|
| Reflex, Startle | 1 | 2017 | 34 | 0.140 |
Why?
|
| Exploratory Behavior | 3 | 2013 | 54 | 0.140 |
Why?
|
| p21-Activated Kinases | 1 | 2017 | 58 | 0.130 |
Why?
|
| Antibodies | 1 | 1998 | 371 | 0.130 |
Why?
|
| Male | 16 | 2017 | 65522 | 0.120 |
Why?
|
| Cells, Cultured | 4 | 2006 | 3131 | 0.120 |
Why?
|
| Neurons | 3 | 2011 | 2050 | 0.120 |
Why?
|
| Maze Learning | 2 | 2013 | 126 | 0.110 |
Why?
|
| Pain | 1 | 2017 | 469 | 0.110 |
Why?
|
| RNA, Messenger | 2 | 2000 | 2876 | 0.100 |
Why?
|
| Promyelocytic Leukemia Protein | 1 | 2013 | 13 | 0.100 |
Why?
|
| Conditioning, Operant | 1 | 2013 | 17 | 0.100 |
Why?
|
| Peptide Fragments | 4 | 2001 | 828 | 0.100 |
Why?
|
| Amino Acid Sequence | 6 | 2002 | 2785 | 0.100 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2013 | 81 | 0.090 |
Why?
|
| Molecular Sequence Data | 6 | 2002 | 3960 | 0.090 |
Why?
|
| Time Factors | 3 | 2011 | 6545 | 0.090 |
Why?
|
| Silver Staining | 1 | 2011 | 5 | 0.090 |
Why?
|
| Methoxyhydroxyphenylglycol | 1 | 2011 | 36 | 0.090 |
Why?
|
| Pyrones | 1 | 2011 | 6 | 0.090 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2011 | 26 | 0.090 |
Why?
|
| Interferon-beta | 2 | 2002 | 54 | 0.090 |
Why?
|
| Vaccination | 3 | 2002 | 1016 | 0.090 |
Why?
|
| Female | 14 | 2017 | 71436 | 0.090 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2011 | 99 | 0.080 |
Why?
|
| Patch-Clamp Techniques | 1 | 2011 | 300 | 0.080 |
Why?
|
| Electric Stimulation | 1 | 2011 | 288 | 0.080 |
Why?
|
| Immunodominant Epitopes | 2 | 2001 | 52 | 0.080 |
Why?
|
| Quinolines | 1 | 2011 | 115 | 0.080 |
Why?
|
| Behavior, Animal | 2 | 2009 | 522 | 0.080 |
Why?
|
| Th1 Cells | 2 | 2000 | 159 | 0.080 |
Why?
|
| Schizophrenic Psychology | 1 | 2009 | 85 | 0.080 |
Why?
|
| Raptors | 1 | 2008 | 6 | 0.080 |
Why?
|
| Epitopes | 2 | 2001 | 444 | 0.080 |
Why?
|
| Th2 Cells | 2 | 2000 | 189 | 0.080 |
Why?
|
| Tacrolimus Binding Protein 1A | 1 | 2008 | 20 | 0.080 |
Why?
|
| Digestive System | 2 | 1999 | 64 | 0.080 |
Why?
|
| Humans | 17 | 2017 | 133257 | 0.080 |
Why?
|
| Exercise Test | 1 | 2010 | 263 | 0.070 |
Why?
|
| Protein Kinases | 1 | 2008 | 340 | 0.070 |
Why?
|
| Centrifugation | 1 | 2006 | 25 | 0.060 |
Why?
|
| Peptides | 2 | 2001 | 863 | 0.060 |
Why?
|
| Schizophrenia | 1 | 2009 | 330 | 0.060 |
Why?
|
| Protein Biosynthesis | 1 | 2009 | 677 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2011 | 4917 | 0.060 |
Why?
|
| Environment | 1 | 2007 | 154 | 0.060 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2006 | 137 | 0.060 |
Why?
|
| Animals, Newborn | 1 | 2009 | 1041 | 0.060 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 2523 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2006 | 400 | 0.060 |
Why?
|
| Phorbol Esters | 1 | 2005 | 23 | 0.060 |
Why?
|
| Subcellular Fractions | 1 | 2005 | 98 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2011 | 2650 | 0.060 |
Why?
|
| Superoxides | 1 | 2005 | 132 | 0.060 |
Why?
|
| Organ Culture Techniques | 1 | 2005 | 160 | 0.060 |
Why?
|
| Antibody Formation | 2 | 2002 | 273 | 0.060 |
Why?
|
| Immunophenotyping | 2 | 2003 | 345 | 0.060 |
Why?
|
| Biological Transport | 1 | 2005 | 367 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2010 | 868 | 0.060 |
Why?
|
| Lymphocyte Count | 2 | 2002 | 123 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2006 | 1136 | 0.050 |
Why?
|
| Middle Aged | 7 | 2003 | 28950 | 0.050 |
Why?
|
| Adoptive Transfer | 2 | 2002 | 240 | 0.050 |
Why?
|
| Adult | 7 | 2003 | 31646 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 2000 | 60 | 0.050 |
Why?
|
| Molecular Mimicry | 1 | 2003 | 25 | 0.050 |
Why?
|
| Autoantigens | 1 | 2003 | 115 | 0.050 |
Why?
|
| Cross Reactions | 1 | 2003 | 193 | 0.050 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2002 | 57 | 0.050 |
Why?
|
| Antibody Specificity | 2 | 2000 | 198 | 0.050 |
Why?
|
| Virion | 1 | 2002 | 151 | 0.050 |
Why?
|
| HLA-DR2 Antigen | 1 | 2001 | 6 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1730 | 0.040 |
Why?
|
| Antigen Presentation | 1 | 2001 | 117 | 0.040 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2000 | 57 | 0.040 |
Why?
|
| Herpesviridae Infections | 1 | 2002 | 146 | 0.040 |
Why?
|
| Erythroid Precursor Cells | 1 | 2000 | 24 | 0.040 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2000 | 40 | 0.040 |
Why?
|
| Remission, Spontaneous | 1 | 2000 | 69 | 0.040 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2000 | 11 | 0.040 |
Why?
|
| Receptors, CCR5 | 1 | 2000 | 31 | 0.040 |
Why?
|
| Conserved Sequence | 1 | 2001 | 299 | 0.040 |
Why?
|
| Chemokine CCL5 | 1 | 2000 | 52 | 0.040 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2000 | 42 | 0.040 |
Why?
|
| Antibodies, Blocking | 1 | 2000 | 63 | 0.040 |
Why?
|
| Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 1999 | 5 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2006 | 1152 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2000 | 834 | 0.040 |
Why?
|
| Clone Cells | 4 | 2001 | 180 | 0.040 |
Why?
|
| Cell Wall | 1 | 1999 | 40 | 0.040 |
Why?
|
| Hot Temperature | 1 | 1999 | 145 | 0.040 |
Why?
|
| Lymphatic System | 1 | 1999 | 19 | 0.040 |
Why?
|
| Mice, Inbred C3H | 1 | 1999 | 122 | 0.040 |
Why?
|
| Peyer's Patches | 1 | 1999 | 22 | 0.040 |
Why?
|
| Polymyxin B | 1 | 1999 | 47 | 0.040 |
Why?
|
| Ascitic Fluid | 1 | 1999 | 31 | 0.040 |
Why?
|
| Cold Temperature | 1 | 1999 | 86 | 0.040 |
Why?
|
| Immunity, Mucosal | 1 | 1999 | 94 | 0.040 |
Why?
|
| Cytoplasm | 1 | 1999 | 301 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1999 | 234 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2000 | 391 | 0.040 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1999 | 211 | 0.040 |
Why?
|
| Spleen | 1 | 1999 | 286 | 0.040 |
Why?
|
| Immunization | 1 | 1999 | 315 | 0.030 |
Why?
|
| Rabbits | 1 | 1998 | 709 | 0.030 |
Why?
|
| Cell Movement | 1 | 2000 | 906 | 0.030 |
Why?
|
| Eating | 1 | 1999 | 393 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2002 | 823 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2010 | 606 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1999 | 624 | 0.030 |
Why?
|
| Stem Cells | 1 | 2001 | 748 | 0.030 |
Why?
|
| Epitopes, T-Lymphocyte | 3 | 2001 | 130 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 1999 | 1582 | 0.030 |
Why?
|
| Feces | 1 | 1999 | 780 | 0.030 |
Why?
|
| Body Weight | 1 | 1999 | 1035 | 0.030 |
Why?
|
| Lymphocyte Activation | 3 | 2001 | 687 | 0.030 |
Why?
|
| Aged | 2 | 2001 | 21475 | 0.020 |
Why?
|
| Dinoprost | 1 | 2010 | 30 | 0.020 |
Why?
|
| Adaptation, Ocular | 1 | 2010 | 18 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 2010 | 108 | 0.020 |
Why?
|
| Buthionine Sulfoximine | 1 | 2010 | 28 | 0.020 |
Why?
|
| Spin Labels | 1 | 2010 | 38 | 0.020 |
Why?
|
| Cyclic N-Oxides | 1 | 2010 | 29 | 0.020 |
Why?
|
| Malondialdehyde | 1 | 2010 | 62 | 0.020 |
Why?
|
| Physical Conditioning, Animal | 1 | 2010 | 98 | 0.020 |
Why?
|
| Glutathione | 1 | 2010 | 198 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 748 | 0.020 |
Why?
|
| Neuroprotective Agents | 1 | 2010 | 169 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2008 | 173 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2000 | 684 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 1303 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2008 | 365 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2008 | 453 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2008 | 1706 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 1531 | 0.010 |
Why?
|
| Rats | 1 | 2010 | 3851 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 2002 | 216 | 0.010 |
Why?
|
| Dimerization | 1 | 2001 | 153 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2001 | 212 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 2000 | 100 | 0.010 |
Why?
|
| Chemokine CCL4 | 1 | 2000 | 13 | 0.010 |
Why?
|
| Chemokine CCL3 | 1 | 2000 | 16 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2000 | 165 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 2000 | 131 | 0.010 |
Why?
|
| Interferon beta-1a | 1 | 2000 | 20 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2002 | 223 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2000 | 147 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 1999 | 6 | 0.010 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 1999 | 13 | 0.010 |
Why?
|
| Neutralization Tests | 1 | 2000 | 237 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2000 | 316 | 0.010 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 1999 | 6 | 0.010 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 1999 | 15 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 1999 | 106 | 0.010 |
Why?
|
| Alanine | 1 | 1999 | 184 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2000 | 188 | 0.010 |
Why?
|
| Virus Replication | 1 | 2002 | 635 | 0.010 |
Why?
|
| DNA Primers | 1 | 1999 | 656 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 1999 | 640 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 1999 | 415 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1999 | 911 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2000 | 536 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1999 | 356 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2000 | 542 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2002 | 1468 | 0.010 |
Why?
|
| Protein Binding | 1 | 2001 | 1852 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 1998 | 439 | 0.010 |
Why?
|
| Disease Progression | 1 | 2002 | 2246 | 0.010 |
Why?
|
| Base Sequence | 1 | 1999 | 3153 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2001 | 3046 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2002 | 13103 | 0.000 |
Why?
|